Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Thyrocare Technologies has announced the appointment of Rajdeep Panwar as Chief Commercial Officer. The appointment forms part of the company’s leadership structure as it advances its commercial strategy and customer engagement across India.

Rajdeep Panwar has experience in the healthcare and diagnostics sector, with a background covering profit and loss management, business expansion, planning, and scaling diagnostic operations. Over the course of his career, he has been involved in the launch and management of more than 200 diagnostic laboratories and has been a founding team member of two healthcare ventures.

Before joining Thyrocare, Panwar served as Director at GHL Pharma & Diagnostics Ltd. (GHL–Medanta), where he was involved in the expansion of Medanta Labs across North India. His professional experience also includes leadership roles at Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs. Across these organisations, he has worked on business expansion, commercial strategy, technical operations, customer support, process management, accreditation, and organisational change.

Commenting on his appointment, Rajdeep Panwar, Chief Commercial Officer of Thyrocare, said, “I am excited to join Thyrocare at a pivotal phase of its growth. The company’s mission to make high-quality diagnostics affordable and accessible across India strongly resonates with me. With its deep partner network and strong scientific foundation, Thyrocare is well positioned to get closer to patients and drive meaningful impact at scale.”

Rahul Guha, Managing Director and CEO of API Holdings, said, “As Thyrocare continues to scale, strengthening our leadership team is critical, and particularly having strong commercial leadership is key. Rajdeep brings deep experience in building and expanding diagnostics businesses in India. We believe his leadership will help strengthen our market approach and deepen engagement with customers and partners. In combination with Dr. Kinha, who recently joined us as Chief Operating Officer (COO) and brings deep operational and quality expertise, the Thyrocare leadership team is best in class and well positioned to win in this growing market.”

In his role as Chief Commercial Officer, Panwar will be responsible for the profit and loss of Thyrocare and will lead the company’s commercial functions. These include franchise operations, corporate business, direct-to-consumer channels, customer relationship management, customer operations, catalogue management, and radiology services. His responsibilities include revenue growth, customer experience, and expansion of Thyrocare’s presence across India.

Thyrocare, part of API Holdings, stated that the appointment aligns with its focus on expanding access to diagnostics across the country.